Al Altomari

Track

Insider profile

Currently holds a position at Agile Therapeutics Inc

Performance

Overall performance
2.1
Performance over holding periods
2.1
30 days 90 days 120 days
Average return -10% 8.2% 15.1%
Success rate 15% 68% 82%
Transactions
6 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chairman of the Board, President, Chief Executive Officer Agile Therapeutics Inc Oct. 5, 2016 -
President, Chief Executive Officer, Director Agile Therapeutics Inc Oct. 1, 2010 - Oct. 5, 2016
Al Altomari's trades of Insmed Incorporated's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
197.71
Quantity 85,122
Value US$4,561,352
Transaction date
Proposed sale
Price
60.55
Quantity 50,192
Value US$2,992,920
Transaction date
Purchase
Price
1.61
Quantity 20,000 +4.3%
Value US$32,200
Transaction date
Planned sale
Price
39.57
Quantity 20,000 -48.9%
Value US$791,400
Transaction date
Purchase
Price
1.06
Quantity 5,000 +8.9%
Value US$5,300
Transaction date
Purchase
Price
2.34
Quantity 5,000 +17.6%
Value US$11,700
Transaction date
Purchase
Price
2.71
Quantity 10,000 +3.3%
Value US$27,100
Transaction date
Planned sale
Price
30.00
Quantity 5,500 -17.5%
Value US$165,000
Transaction date
Planned sale
Price
27.50
Quantity 5,500 -14.9%
Value US$151,250
Transaction date
Planned sale
Price
25.00
Quantity 5,500 -13.0%
Value US$137,500
Transaction date
Planned sale
Price
22.50
Quantity 5,500 -11.5%
Value US$123,750
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-08-13 2025-08-13
PrS Proposed sale
85,122
197.71
US$4,561,352 		85,122 197.71 US$4,561,352
2025-06-10 2025-06-10
PrS Proposed sale
50,192
60.55
US$2,992,920 		50,192 60.55 US$2,992,920
2022-08-29 2022-08-26
B Purchase
27,497 +17.2%
184.22
US$2,830,511 		27,497 +17.2% 184.22 US$2,830,511
2021-10-14 2021-10-13
B Purchase
58,824
0.00
US$0 		58,824 0.00 US$0
2021-05-19 2021-05-18
B Purchase
20,000 +4.3%
1.61
US$32,200 		20,000 +4.3% 1.61 US$32,200
2021-03-23 2021-03-23
B Purchase
12,500 +2.7%
2.00
US$25,030 		12,500 +2.7% 2.00 US$25,030
2020-12-09 2020-12-07
PlS Planned sale
20,000 -48.9%
39.57
US$791,400 		20,000 -48.9% 39.57 US$791,400
2020-11-24 2020-11-23
B Purchase
5,000 +8.9%
1.06
US$5,300 		5,000 +8.9% 1.06 US$5,300
2020-03-27 2020-03-26
B Purchase
5,000 +17.6%
2.34
US$11,700 		5,000 +17.6% 2.34 US$11,700
2020-02-27 2020-02-27
B Purchase
10,000 +3.3%
2.71
US$27,100 		10,000 +3.3% 2.71 US$27,100
2019-06-11 2019-06-10
B Purchase
20,000 +8.4%
1.27
US$25,400 		20,000 +8.4% 1.27 US$25,400
2019-03-26 2019-03-25
B Purchase
25,000 +11.7%
1.54
US$38,500 		25,000 +11.7% 1.54 US$38,500
2019-02-27 2019-02-26
PlS Planned sale
5,500 -17.5%
30.00
US$165,000 		5,500 -17.5% 30.00 US$165,000
2019-02-20 2019-02-15
PlS Planned sale
5,500 -14.9%
27.50
US$151,250 		5,500 -14.9% 27.50 US$151,250
2019-02-07 2019-02-05
PlS Planned sale
5,500 -13.0%
25.00
US$137,500 		5,500 -13.0% 25.00 US$137,500
2019-01-14 2019-01-10
PlS Planned sale
5,500 -11.5%
22.50
US$123,750 		5,500 -11.5% 22.50 US$123,750